Targeting ER stress–induced autophagy overcomes BRAF inhibitor resistance in melanoma
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Melanomas that result from mutations in the gene encoding BRAF often become resistant to BRAF inhibition (BRAFi), with multiple mechanisms contributing to resistance. While therapy-induced autophagy promotes resistance to a number of therapies, especially those that target PI3K/mTOR signaling, its role as an adaptive resistance mechanism to BRAFi is not well characterized. Using tumor biopsies from BRAF(V600E) melanoma patients treated either with BRAFi or with combined BRAF and MEK inhibition, we found that BRAFi-resistant tumors had increased levels of autophagy compared with baseline. Patients with higher levels of therapy-induced autophagy had drastically lower response rates to BRAFi and a shorter duration of progression-free survival. In BRAF(V600E) melanoma cell lines, BRAFi or BRAF/MEK inhibition induced cytoprotective autophagy, and autophagy inhibition enhanced BRAFi-induced cell death. Shortly after BRAF inhibitor treatment in melanoma cell lines, mutant BRAF bound the ER stress gatekeeper GRP78, which rapidly expanded the ER. Disassociation of GRP78 from the PKR-like ER-kinase (PERK) promoted a PERK-dependent ER stress response that subsequently activated cytoprotective autophagy. Combined BRAF and autophagy inhibition promoted tumor regression in BRAFi-resistant xenografts. These data identify a molecular pathway for drug resistance connecting BRAFi, the ER stress response, and autophagy and provide a rationale for combination approaches targeting this resistance pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Inhibition of BRAFV600E with vemurafenib induces autophagy by inhibition of the mTOR signaling pathway, and autophagy has been shown to promote survival of melanoma cells after vemurafenib81,85.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [81]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Induction of autophagy has been suggested to be a pro-survival mechanism for melanoma cells79,81,82.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720
The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
Walter, P., & Ron, D. (2011) · Science · doi:10.1126/science.1209038 · Cited by 5,924
Guidelines for the use and interpretation of assays for monitoring autophagy
Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J. A., et al. (2012) · Autophagy · doi:10.4161/auto.19496 · Cited by 4,330 · cited 7×
“LC3 is an ubiquitin-like cytoplasmic protein that is conjugated to the surface of AVs as they are formed.”
InfluentialSelf-citationClonogenic assay of cells in vitro
Franken, N. A. P., Rodermond, H. M., Stap, J., Haveman, J., & van Bree, C. (2006) · Nature Protocols · doi:10.1038/nprot.2006.339 · Cited by 4,188
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
Hauschild, A., Grob, J.-J., Demidov, L. V., Jouary, T., Gutzmer, R., Millward, M., Rutkowski, P., Blank, C. U., Miller, W. H., Kaempgen, E., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60868-x · Cited by 2,989
Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response
Bertolotti, A., Zhang, Y., Hendershot, L. M., Harding, H. P., & Ron, D. (2000) · Nature Cell Biology · doi:10.1038/35014014 · Cited by 2,860
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations
Flaherty, K. T., Infante, J. R., Daud, A., Gonzalez, R., Kefford, R. F., Sosman, J., Hamid, O., Schuchter, L., Cebon, J., Ibrahim, N., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1210093 · Cited by 2,810
Self-citationPhosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy
Egan, D. F., Shackelford, D. B., Mihaylova, M. M., Gelino, S., Kohnz, R. A., Mair, W., Vasquez, D. S., Joshi, A., Gwinn, D. M., Taylor, R., et al. (2011) · Science · doi:10.1126/science.1196371 · Cited by 2,600
Direct observation of individual endogenous protein complexes in situ by proximity ligation
Söderberg, O., Gullberg, M., Jarvius, M., Ridderstråle, K., Leuchowius, K.-J., Jarvius, J., Wester, K., Hydbring, P., Bahram, F., Larsson, L.-G., et al. (2006) · Nature Methods · doi:10.1038/nmeth947 · Cited by 2,419 · cited 9×
“PLA was performed using Duolink In Situ fluorescence technology (Olink Bioscience).”
Influential
Cited by
Items 301–400 of 490
The epigenome and the many facets of cancer drug tolerance
Moore, P. C., Henderson, K. W., & Classon, M. (2023) · Advances in cancer research · doi:10.1016/bs.acr.2022.12.002 · Cited by 15
The role of autophagy in metal-induced urogenital carcinogenesis
Saran, U., Tyagi, A., Chandrasekaran, B., Ankem, M. K., & Damodaran, C. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.022 · Cited by 15
Dangerous liaisons: flirtations between oncogenic BRAF and GRP78 in drug-resistant melanomas
Shenolikar, S. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74609 · Cited by 15
Targeting Autophagy in BRAF-Mutant Tumors
Thorburn, A. M., & Morgan, M. J. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0222 · Cited by 15
Wan, Q., Jin, L., Su, Y., Sang, X., Wang, S., cheng, Y., Liu, Y., Liu, Y., Li, C., & Wang, Z. (2020) · IUBMB Life · doi:10.1002/iub.2258 · Cited by 14
Enhancing anti-tumor immunity by autophagy inhibition
Thorburn, A. M., & Towers, C. G. (2021) · Nature Cancer · doi:10.1038/s43018-021-00214-8 · Cited by 14
Bromodomain inhibition overcomes treatment resistance in distinct molecular subtypes of melanoma
Dar, A. A., Bezrookove, V., Nosrati, M., Ice, R. J., Patino, J. M., Vaquero, E. M., Parrett, B. M., Leong, S. P. L., Kim, K. B., Debs, R. J., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2206824119 · Cited by 13
Wu, X., Song, J., Zhang, Y., Kuai, L., Liu, C., Ma, X., Li, B., Zhang, Z., & Luo, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112244 · Cited by 13
Self-citationDivergent effects of acute and chronic PPT1 inhibition in melanoma
Crissey, M. A. S., Versace, A. M., Bhardwaj, M., Jain, V., Liu, S., Singh, A., Beer, L. A., Tang, H., Villanueva, J., Gimotty, P. A., et al. (2024) · Autophagy · doi:10.1080/15548627.2024.2403152 · Cited by 13
Self-citationER stress and/or ER-phagy in drug resistance? Three coincidences are proof
Panda, S. K., Sanchez-Pajares, I. R., Rehman, A., Vecchio, V. D., Mele, L. L., Chipurupalli, S., Robinson, N., & Desiderio, V. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02232-w · Cited by 13
Hirata, A. S., Clair, J. J. L., Jimenez, P. C., Costa-Lotufo, L. V., & Fenical, W. (2022) · Marine Drugs · doi:10.3390/md20050301 · Cited by 13
Targeting autophagy by antipsychotic phenothiazines: potential drug repurposing for cancer therapy
Lopes, R. D. M., de Souza, A. C. S., Otręba, M., Rzepecka‐Stojko, A., Tersariol, I. L. S., & Rodrigues, T. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116075 · Cited by 14
Wang, Y., Li, N., Chen, X., Zhao, Y., Qu, L., & Cai, D. (2024) · Cell Biology and Toxicology · doi:10.1007/s10565-024-09964-4 · Cited by 14
RAS-mediated tumor stress adaptation and the targeting opportunities it presents
Redding, A., Aplin, A. E., & Grabocka, E. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049280 · Cited by 13
Zhai, Z., Vaddi, P. K., Samson, J. M., Takegami, T., & Fujita, M. (2020) · Pharmaceuticals · doi:10.3390/ph14010023 · Cited by 13
Immune-checkpoint inhibitors march on, now in combinations
Sheridan, C. (2014) · Nature Biotechnology · doi:10.1038/nbt0414-297 · Cited by 13
Hatat, A., Benoit‐Pilven, C., Pucciarelli, A., de Fraipont, F., Lamothe, L., Perron, P., Rey, A., Levra, M. G., Toffart, A., Auboeuf, D., et al. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13229 · Cited by 12
Distinct Types of Regulated Cell Death in Melanoma
Wu, Q., Liang, S. A., Shi, G.-J., Meng, G., & Yang, S. (2025) · Cells · doi:10.3390/cells14110823 · Cited by 12
Reduced maternal SCFAs in GDM diminish GPR43 signaling and induce offspring CAKUT
Wang, H., Kang, T., & Li, W. (2025) · Communications Biology · doi:10.1038/s42003-025-08469-y · Cited by 12
Thorburn, J., Staskiewicz, L., Goodall, M. L., Dimberg, L. Y., Frankel, A. E., Ford, H. L., & Thorburn, A. M. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.106070 · Cited by 12
The Cytoprotective Role of Autophagy in Response to BRAF-Targeted Therapies
Elshazly, A. M., & Gewirtz, D. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914774 · Cited by 13
Mourah, S., Louveau, B., & Dumaz, N. (2019) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000603 · Cited by 12
Change or die: Targeting adaptive signaling to kinase inhibition in cancer cells
Rebecca, V. W., & Smalley, K. S. M. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.031 · Cited by 12
BRAF inhibition promotes ER stress-mediated cell death in uveal melanoma
Zhaon, Y., Wang, Y., Zhang, L., Wang, W., Fahey, T. J., & Yao, K. (2022) · Neoplasma · doi:10.4149/neo_2022_220428n462 · Cited by 11
Navigating therapeutic prospects by modulating autophagy in colorectal cancer
Rajendran, D., & Oon, C. E. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123121 · Cited by 11
Cell Death Modalities in Therapy of Melanoma
Wang, M., Zhao, J., Tang, M.-X., Li, M., Zhao, H., Li, Z., & Liu, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083475 · Cited by 11
The role of non-coding RNAs in the regulation of cell death pathways in melanoma
Metanat, Y., Sviridova, M., Al-Nuaimi, B. N., Janbazi, F., Jalali, M., Ghalamkarpour, N., Khodabandehloo, E., & Ahmadi, E. (2025) · Discover Oncology · doi:10.1007/s12672-025-02888-3 · Cited by 11
Quenching thirst with poison? Paradoxical effect of anticancer drugs
Chai, K., Wang, C., Zhou, J., Mu, W., Gao, M., Fan, Z., & Lv, G. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106987 · Cited by 11
Targeting JUNB to modulate M2 macrophage polarization in preeclampsia
Jiang, P., Zhu, X., Jiang, Y., Li, H., & Luo, Q. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167194 · Cited by 11
The importance of autophagy regulation in obstructive sleep apnea
Ding, H., Guo, H., & Cao, J. (2021) · Sleep And Breathing · doi:10.1007/s11325-020-02261-4 · Cited by 11
Cellular Self-Digestion and Persistence in Bacteria
Mohiuddin, S. G., Ghosh, S., Ngo, H. G., Sensenbach, S., Karki, P., Dewangan, N. K., Angardi, V., & Orman, M. A. (2021) · Microorganisms · doi:10.3390/microorganisms9112269 · Cited by 11
A Review on Autophagy in Orofacial Neuropathic Pain
Shrivastava, M., & Ye, L. (2022) · Cells · doi:10.3390/cells11233842 · Cited by 11
Geng, J., Liang, B., Zhang, Z., Shan, F., Zhao, X., & Yuan, Y. (2025) · Communications Biology · doi:10.1038/s42003-025-08147-z · Cited by 10
An overview of autophagy inhibition as a potential clinical strategy in cancer therapy
Elshazly, A. M., Hosseini, N., Elzahed, A. A., & Gewirtz, D. A. (2025) · Molecular Pharmacology · doi:10.1016/j.molpha.2025.100056 · Cited by 10
The hidden hand of endoplasmic reticulum stress in anticancer drug resistance
Khan, J. T., Sood, S., Piedra, V., Seker, E., Rajak, H., Karthikeyan, C., Ashby, C. R., Pathak, R., & Tiwari, A. K. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104998 · Cited by 10
Unraveling the regulatory role of endoplasmic-reticulum-associated degradation in tumor immunity
Qin, X., Denton, W. D., Huiting, L. N., Smith, K. S., & Feng, H. (2020) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2020.1784085 · Cited by 10
Pérez, C. N., Falcón, C. R., Mons, J. D., Orlandi, F. C., Sangiacomo, M., Fernandez-Muñoz, J. M., Guerrero-Gimenez, M. E., Benito, P. G., Colombo, M. I., Zoppino, F. C. M., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166801 · Cited by 12
Modulation of autophagy in human diseases strategies to foster strengths and circumvent weaknesses
Xu, S., Sui, S., Zhang, X., Pang, B., Wan, L., & Pang, D. (2019) · Medicinal Research Reviews · doi:10.1002/med.21571 · Cited by 10
Purinergic Ca2+ Signaling as a Novel Mechanism of Drug Tolerance in BRAF-Mutant Melanoma
Stauffer, P. E., Brinkley, J., Jacobson, D. A., Quaranta, V., & Tyson, D. R. (2024) · Cancers · doi:10.3390/cancers16132426 · Cited by 9
McClure, E., Carr, M. J., & Zager, J. S. (2020) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2020.1796646 · Cited by 9
D’Ambrosio, L., Greco, M. E., Forte, M., Vecchio, D., Schiavon, S., Nonno, F. D., Tahir, S., Picchio, V., Cozzolino, C., Sarto, G., et al. (2025) · Biology Direct · doi:10.1186/s13062-025-00703-1 · Cited by 9
Kim, J., Stewart, P. A., Borne, A. L., Fang, B., Welsh, E. A., Chen, Y. A., Eschrich, S. A., Koomen, J. M., & Haura, E. B. (2016) · Proteomes · doi:10.3390/proteomes4020016 · Cited by 8
Yeom, H., Hwang, S., Kim, H., & Lee, M. (2021) · Toxicological Research · doi:10.1007/s43188-021-00109-x · Cited by 8
Althobaiti, N. A., Al-Abbas, N. S., Alsharif, I., Albalawi, A. E., Almars, A. I., Basabrain, A. A., Jafer, A., Ellatif, S. A. A., Bauthman, N. M., Almohaimeed, H. M., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167353 · Cited by 8
Role of mitochondria and potential of mitochondria-targeted therapy in BRAF mutant cancer: A review
Gao, Y., & Zheng, H. S. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104484 · Cited by 8
Zhang, X., Shao, W., Gao, Y., & Wang, X. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111664 · Cited by 8
Proteotoxicity and endoplasmic reticulum stress-mediated cell death
Wang, M., Law, M. E., & Law, B. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-814208-0.00006-3 · Cited by 8
Konstantakou, E. G., Velentzas, A. D., Anagnostopoulos, A. K., Giannopoulou, A. F., Anastasiadou, E., Papassideri, I. S., Voutsinas, G. E., Tsangaris, G. T., & Stravopodis, D. J. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2017.11.015 · Cited by 8
Bułakowska, A., Slawinski, J. J., Siedlecka-Kroplewska, K., Stasiłojć, G., Serocki, M., & Heldt, M. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104309 · Cited by 8
Chen, R., Niu, L., Wu, L., He, Y., Liu, G., & Hong, K. (2022) · Medicine · doi:10.1097/md.0000000000030280 · Cited by 7
The PKR-Like Endoplasmic Reticulum Kinase Promotes the Dissemination of Myc-Induced Leukemic Cells
Gui, J., Katlinski, K. V., Koumenis, C., Diehl, J. A., & Fuchs, S. Y. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0002 · Cited by 7
Self-citationAutophagy in Cancer: A Metabolic Perspective
Sikder, S., Mondal, A., Das, C., & Kundu, T. K. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-07634-3_5 · Cited by 7
Servante, J., Estranero, J. G., Meijer, L., Layfield, R., & Grundy, R. G. (2018) · Oncotarget · doi:10.18632/oncotarget.26186 · Cited by 7
Yeom, H., Hwang, S., Han, B., & Lee, M. (2021) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2020.203 · Cited by 7
Therapeutic Strategies for Drug-resistant Melanoma and Their Clinical Implications
Huang, K., & Kim, M.-O. (2025) · Journal of Cancer Prevention · doi:10.15430/jcp.24.028 · Cited by 6
Crosstalk Between Autophagy and Paraptosis: A New Frontier in Cancer Therapy
Hanson, S., Murugan, D., Jinsha, P. V., Binoy, A., Nair, B. G., & Mishra, N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052234 · Cited by 6
Impact of LITAF on Mitophagy and Neuronal Damage in Epilepsy via MCL‐1 Ubiquitination
Min, F., Dong, Z., Zhong, S.-S., Li, Z., Wu, H., Zhang, S., Zhang, L., & Zeng, T. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70191 · Cited by 6
Therapeutic interventions to disrupt the protein synthetic machinery in melanoma
Kardos, G. R., & Robertson, G. P. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12391 · Cited by 6
Induction of Autophagy and Apoptosis in Melanoma Treated With Palladacycle Complexes
Aliwaini, S. H., Bleloch, J., Kimani, S., & Prince, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-805421-5.00012-4 · Cited by 6
Sciarretta, F., Fulci, C., Palumbo, C., Rotili, D., Tentori, L., Graziani, G., & Caccuri, A. M. (2019) · Chemotherapy · doi:10.1159/000503339 · Cited by 6
Autophagy in cancer and protein conformational disorders
Attanasio, S. (2025) · FEBS Letters · doi:10.1002/1873-3468.70061 · Cited by 5
Pan, J., Chen, Y., Yan, Y., Li, P., Ni, F., & He, H. (2025) · Cancer & Metabolism · doi:10.1186/s40170-025-00398-y · Cited by 5
Yu, T., Ben, S., Ma, L., Jiang, L., Chen, S., Lin, Y., Chen, T., Li, S., & Zhu, L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.876424 · Cited by 5
Targeted Therapy for Melanomas Without BRAF V600 Mutation
Choi, J. S., & Chandra, S. (2022) · Current Oncology Reports · doi:10.1007/s11912-022-01306-z · Cited by 5
Niessner, H., Hüsch, A., Kosnopfel, C., Meinhardt, M., Westphal, D., Meier, F. E., Schilling, B., & Sinnberg, T. W. (2023) · Cancers · doi:10.3390/cancers15235521 · Cited by 5
Li, Y., Feng, Y., & Chen, D. (2024) · Cancers · doi:10.3390/cancers16234060 · Cited by 5
Stressing out melanoma with an anti‐ GRP 78 compound
Bu, Y., & Diehl, J. A. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12499 · Cited by 5
Annexin A1: a key regulator of T cell function and bone marrow adiposity in aplastic anaemia
Liu, X., Li, X., Li, H., Guan, B., Jiang, Y. Z., Zheng, C., & Kong, D. (2024) · The Journal of Physiology · doi:10.1113/jp286148 · Cited by 4
Dual regulation of Atf3 and Lonp1 as therapeutic targets in cerebral ischaemia-reperfusion injury
Fan, W., Zhou, M., Zhou, L., Tong, J., Tan, J., Shi, W., & Yu, B. (2025) · Stroke and Vascular Neurology · doi:10.1136/svn-2024-003324 · Cited by 4
NVP-BEZ235 enhances autophagy and ameliorates cognitive deficits by targeting tauopathies
Alsharif, I. (2025) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2025.104988 · Cited by 4
LD-110, a potent LSD1 PROTAC degrader, suppresses tumor growth by inducing ER stress and apoptosis
Zhai, D., Zhuo, J., Yin, Y., Li, L., Liang, M., Zhou, X., Liu, L., Chen, L., Xiong, X., Yang, Y. P., et al. (2025) · 中国科学通报:英文版 · doi:10.1016/j.scib.2025.10.024 · Cited by 4
Current Perspectives on Pediatric Low-Grade Gliomas: Focus on BRAF and MEK Inhibition
Suh, J. K., & Koh, K. (2026) · Brain Tumor Research and Treatment · doi:10.14791/btrt.2025.0026 · Cited by 4
Fokken, C., Silbern, I., Shomroni, O., Pan, K., Ryazanov, S., Leonov, A., Winkler, N., Urlaub, H., Griesinger, C., & Becker, D. (2024) · Melanoma Research · doi:10.1097/cmr.0000000000000982 · Cited by 4
Autophagy in cancer: friend or foe?
Vega-Rubín-de-Celis, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822003-0.00009-7 · Cited by 4
Volpe, A. R., Carmignani, M., & Cesare, P. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1073338 · Cited by 4
Räsänen, K., Dang, K. X., Mustonen, H. K., Ho, T. H., Lintula, S., Koistinen, H. K., Stenman, U., Haglund, C. H., & Stenman, J. J. E. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12160 · Cited by 4
Advances in the role of autophagy in the development of retinoblastoma (Review)
Wan, T., Fu, M., Wu, Z., Gao, X. J., & Zhou, S. (2021) · Oncology Letters · doi:10.3892/ol.2021.12893 · Cited by 4
Raufi, A. G., Wong, W., Chen, K., Iuga, A. C., Ahmed, F. S., & Manji, G. A. (2020) · JCO Precision Oncology · doi:10.1200/po.20.00134 · Cited by 4
Therapeutic Targeting of Autophagy in Pancreatic Cancer
Foth, M., Garrido‐Laguna, I., & Kinsey, C. G. (2021) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2021.06.001 · Cited by 4
Heat Shock Protein 70 and Cancer
Liu, T., & Cao, S. (2018) · Heat shock proteins · doi:10.1007/978-3-319-89551-2_5 · Cited by 4
GCN2 in Cancer: Molecular Mechanisms to Therapeutic Potential
Prescott, H., Sarwar, M., Dickens, M., & Sattlegger, E. (2026) · Current Cancer Drug Targets · doi:10.2174/0115680096325045241120113825 · Cited by 3
Inhibiting Fatty Acid Oxidation Suppresses Acquired Resistance to Standard Chemotherapy in Melanoma
Choi, W., Ham, W., Park, J., Sim, S. H., Chun, J. W., Kang, M., Kim, C., Hong, W., Koh, E.-B., Kang, J. K., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209873 · Cited by 3
Autophagy in thyroid cancer: Immune suppression and drug resistance
Zhai, H., Sun, P., Bashir, B., Qu, B., Du, Z., Kumar, A. P., Xia, Y., Gangadaran, P., Jha, S. K., Singh, S. K., et al. (2026) · Drug Resistance Updates · doi:10.1016/j.drup.2026.101437 · Cited by 3
Liu, J., Wang, H., & Zhang, C. (2025) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-025-00845-2 · Cited by 3
Jiang, B., Zeng, L., Tan, Y., Feng, W., Jiang, Y., Tang, Y., Zhu, H., Xie, L., Fan, S., & Li, Y. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144308 · Cited by 3
CXCL8/SDC1 axis mediates tumor stem cell interactions to drive remote transfer in thyroid cancer
Wang, W., Zhou, J. W., Tao, B., Kong, N., & Shao, J. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101354 · Cited by 3
Entendiendo las terapias actuales en melanoma metastásico
Rodríguez, R., Parra, A., González, S., Molgó, M., Nicolás Droppelmann, M., Acevedo, F., Peña, J., & Uribe, P. (2016) · Revista médica de Chile · doi:10.4067/s0034-98872016001100011 · Cited by 3
The Role of Endoplasmic Reticulum Stress in Melanoma
Shi, H., Sun, J., & Chen, H. (2021) · International Journal of Dermatology and Venereology · doi:10.1097/jd9.0000000000000214 · Cited by 3
Baenke, F., Dhomen, N. S., Gottlieb, E., & Marais, R. (2019) · Springer eBooks · doi:10.1007/978-1-4614-7147-9_28 · Cited by 3
Baenke, F., Dhomen, N. S., Gottlieb, E., & Marais, R. (2019) · Springer eBooks · doi:10.1007/978-1-4614-7322-0_28-2 · Cited by 3
Zhou, H., Li, G., Kan, L., Yang, M., Liu, Y., Miu, X., Shi, L., Yang, Z., Zheng, X., Chen, H., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30475 · Cited by 3
Zhang, W., Huang, X., Chen, B., Liu, Y., Feng, J., Liu, S., Zhang, R., Yu, X., Duan, T., Zhang, M., et al. (2020) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2020-0455 · Cited by 3
Chang, J., Yan, S., Geng, Z., & Wang, Z. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116511 · Cited by 3
Yen, C. (2016) · Journal of Biomedical Sciencies · doi:10.4172/2254-609x.100021 · Cited by 3
Autophagy Inhibition as a Strategy for Cancer Therapy
Ma, X., Piao, S., Mcafee, Q. W., & Amaravadi, R. K. (2016) · Wiley eBooks · doi:10.1002/9781118978320.ch13 · Cited by 3
Self-citationMetabolism in Pancreatic Cancer
Poursaitidis, I., & Lamb, R. F. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7193-0_68 · Cited by 3
Hu, B., Chai, S., Li, X., Zhang, Q., Jin, M., & Zhang, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1612217 · Cited by 2
Comprehensive analysis of BRCA1/2 mutations, “BRCAness” and PARP inhibitors in melanoma
Stylianakis, D., Stylianakis, I., Benjamin, H. A., Martella, S., Tziotis, A., Pellegrino, B., Silva, P. D., Giannakis, M., Perrone, F., Lambertini, M., et al. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104962 · Cited by 2
Jang, Y. W., Bae, W., Ji, S. M., Choi, J., Kim, J., & Jeong, J. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178371 · Cited by 2
Dai, J., Wu, Z., Zhong, J., Wu, X., Liu, Y., Yang, Q., Li, L., Zhang, S., & Zhong, J. (2026) · Cell Death Discovery · doi:10.1038/s41420-025-02772-7 · Cited by 2
Metadata
- Authors
- Ma, X.-H., Piao, S.-F., Dey, S., Mcafee, Q., Karakousis, G., Villanueva, J., Hart, L. S., Levi, S., Hu, J., Zhang, G., Lazova, R., Klump, V., Pawelek, J. M., Xu, X., Xu, W., Schuchter, L. M., Davies, M. A., Herlyn, M., Winkler, J., Koumenis, C., & Amaravadi, R. K.
- Affiliations
- University of Pennsylvania (US)
- The Wistar Institute (US)
- Yale University (US)
- Abramson Cancer Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2014-02-24
- Volume
- 124
- Issue
- 3
- Pages
- 1406-1417
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3934165
- OpenAlex
- W2119735934
- Cited by
- 457
- References
- 52
- Citations by year
- 2026: 11 · 2025: 36 · 2024: 39 · 2023: 27 · 2022: 37 · 2021: 40 · 2020: 40 · 2019: 35 · 2018: 44 · 2017: 44 · 2016: 48 · 2015: 31 · 2014: 24
- FWCI
- 20.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Pennsylvania
- National Institutes of Health
- National Cancer Institute (P01CA114046, R01CA139362, K01CA175269, K23CA120862, R01CA169134, R01CA094214, P30CA016672, P30CA010815, P30CA016520)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- melanoma, BRAF inhibitor resistance, BRAF V600E mutation, endoplasmic reticulum stress, autophagy, cytoprotective autophagy, GRP78, PERK, MEK inhibition, autophagy inhibition, combination therapy, PI3K/mTOR signaling, progression-free survival
- MeSH terms
- Vemurafenib, Endoplasmic Reticulum Chaperone BiP, Animals, Antineoplastic Agents, Autophagy, Humans, Indoles, Melanoma, Mice, Nude, Sulfonamides, Drug Resistance, Neoplasm, Mutation, Missense, MAP Kinase Signaling System, Xenograft Model Antitumor Assays, Cell Line, Tumor, Proto-Oncogene Proteins B-raf, Cell Proliferation, Mice, Endoplasmic Reticulum Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.